CroFab

Drug BTG INTERNATIONAL, INC.
Total Payments
$354,568
Transactions
167
Doctors
130
Companies
2

Payment Trends by Year

Year Amount Transactions Doctors
2024 $353,869 120 88
2020 $698.12 47 42

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $338,560 13 95.5%
Grant $7,500 1 2.1%
Space rental or facility fees (teaching hospital only) $6,750 6 1.9%
Food and Beverage $1,443 102 0.4%
Education $315.42 45 0.1%

Top Doctors Receiving Payments for CroFab — Page 6

Doctor Specialty Location Total Records
, MD Critical Care Medicine Oklahoma City, OK $6.54 1
, M.D Pulmonary Disease Norman, OK $6.54 1
, M.D Emergency Medicine North Little Rock, AR $6.54 1
, DO Family Medicine Sulphur, OK $6.50 1
, APRN, FNP-C Nurse Practitioner Sulpher, LA $3.69 1
, M.D Emergency Medicine Baton Rouge, LA $3.69 1

About CroFab

CroFab is a drug associated with $354,568 in payments to 130 healthcare providers, recorded across 167 transactions in the CMS Open Payments database. The primary manufacturer is BTG INTERNATIONAL, INC..

Payment data is available from 2020 to 2024. In 2024, $353,869 was paid across 120 transactions to 88 doctors.

The most common payment nature for CroFab is "Consulting Fee" ($338,560, 95.5% of total).